Porvair plcs AGM trading update highlights that the groups performance in the first four months of 2026 is in line with expectations, with 5% constant currency revenue growth. Key points include
Strong aerospace order bookscontinued robust nuclear demandand subdued petrochemical sales.
Steady life sciences consumables orders and stable environmental instrument demand in the Laboratory division.
Firm aluminium and superalloys demand in Metal Melt Quality, with progress on the new US manufacturing line and successful Drache acquisition integration.
Unchanged full-year performance expectations, supported by a diversified portfolio, recurring revenue, and disciplined management.
Increased focus on M&A opportunities, with no change to long-term strategic outlook.
Upcoming Capital Markets Event in October 2026 and interim results announcement in June 2026.
Since the provided text does not contain specific financial or debt figures for comparison, I cannot generate an HTML table with year-on-year comparisons. However, I can provide a generic HTML table structure that you can use to input the relevant data if it becomes available:
If you provide the actual financial and debt figures, I can populate this table accordingly.